Cited by 60Receptor Mechanisms and SignalingCardiac Fibrosis and RemodelingProtein Kinase Regulation and GTPase Signaling

RGS2 inhibits β-adrenergic receptor-induced cardiomyocyte hypertrophy

Nunn, Caroline, Zou, Min-Xu, Sobiesiak, Alina J., Roy, Anju A., Kirshenbaum, Lorrie A., Chidiac, Peter·2010·Cellular Signalling

Abstract

The chronic stimulation of certain G protein-coupled receptors promotes cardiomyocyte hypertrophy and thus plays a pivotal role in the development of human heart failure. The beta-adrenergic receptors (beta-AR) are unique among these in that they signal via Gs, whereas others, such as the alpha1-adrenergic (alpha1-AR) and endothelin-1 (ET-1) receptors, predominantly act through Gq. In this study, we investigated the potential role of regulator of G protein signalling 2 (RGS2) in modulating the hypertrophic effects of the beta-AR agonist isoproterenol (ISO) in rat neonatal ventricular cardiomyocytes. We found that ISO-induced hypertrophy in rat neonatal ventricular myocytes was accompanied by the selective upregulation of RGS2 mRNA, with little or no change in RGS1, RGS3, RGS4 or RGS5. The adenylyl cyclase activator forskolin had a similar effect suggesting that it was mediated through cAMP production. To study the role of RGS2 upregulation in beta-AR-dependent hypertrophy, cardiomyocytes were infected with adenovirus encoding RGS2 and assayed for cell growth, markers of hypertrophy, and beta-AR signalling. ISO-induced increases in cell surface area were virtually eliminated by the overexpression of RGS2, as were increases in alpha-skeletal actin and atrial natriuretic peptide. RGS2 overexpression also significantly attenuated ISO-induced extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Akt activation, which may account for, or contribute to, its observed antihypertrophic effects. In contrast, RGS2 overexpression significantly activated JNK MAP kinase, while decreasing the potency but not the maximal effect of ISO on cAMP accumulation. In conclusion, the present results suggest that RGS2 negatively regulates hypertrophy induced by beta-AR activation and thus may play a protective role in cardiac hypertrophy.

Integrity signals

Registry

Crossref · 10.1016/j.cellsig.2010.03.015

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nunn, C., Zou, M.-X., Sobiesiak, A. J., Roy, A. A., Kirshenbaum, L. A., & Chidiac, P.
Affiliations
  • Western University (CA)
  • St. Boniface Hospital (CA)
Corresponding author
Chidiac, Peter
Venue
Cellular Signalling
Publisher
Elsevier BV
Published
2010-08
Volume
22
Issue
8
Pages
1231-1239
ISSN
0898-6568 (ISSN-L)
OpenAlex
W2033577990
Cited by
60
References
38
Citations by year
2025: 5 · 2024: 5 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 5 · 2015: 8 · 2014: 6 · 2013: 3 · 2012: 5
FWCI
2.47
Type
journal article
Language
en
Open access
closed
Locations
  • Cellular Signalling (publishedVersion)
  • PubMed (publishedVersion)
Funders
Canadian Institutes of Health Research
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
RGS2, regulator of G protein signaling, beta-adrenergic receptors, cardiomyocyte hypertrophy, isoproterenol, cAMP signaling, Gs protein, ERK1/2, Akt, JNK MAP kinase, heart failure, neonatal cardiomyocytes, adenoviral overexpression
MeSH terms
Adrenergic beta-Agonists, Animals, Cells, Cultured, Heart Ventricles, Isoproterenol, Signal Transduction, Rats, Sprague-Dawley, Cyclic AMP-Dependent Protein Kinases, GTP-Binding Protein alpha Subunits, Gs, Endothelin-1, RGS Proteins, Myocytes, Cardiac, GTP-Binding Protein alpha Subunits, Gq-G11, Cell Enlargement, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review